TY - JOUR AU - Mulligan, Nikki AU - Schalkwijk, Stein AU - Best, Brookie M. AU - Colbers, Angela AU - Wang, Jiajia AU - Capparelli, Edmund V. AU - Molto, Jose AU - Stek, Alice M. AU - Taylor, Graham AU - Smith, Elizabeth AU - Tenorio, Carmen Hidalgo AU - Chakhtoura, Nahida AU - van Kasteren, Marjo AU - Fletcher, Courtney V. AU - Mirochnick, Mark AU - Burger, David AU - PANNA Network AU - IMPAACT 1026s Study Teams PY - 2016 DO - 10.3389/fphar.2016.00239 SN - 1663-9812 UR - http://hdl.handle.net/10668/19239 T2 - Frontiers in pharmacology AB - Background: The study goal was to describe etravirine pharmacokinetics during pregnancy and postpartum in HIV-infected women.Methods: IMPAACT P1026s and PANNA are on-going, non-randomized, open-label, parallel-group, multi-center phase-IV prospective... LA - en PB - Frontiers media sa KW - etravirine KW - pregnancy KW - HIV KW - pharmacokinetics KW - perinatal transmission KW - Transplacental passage KW - Darunavir KW - Safety KW - Darunavir/ritonavir KW - Pharmacodynamics KW - Combination KW - Enfuvirtide KW - Raltegravir KW - Efficacy KW - Woman TI - Etravirine Pharmacokinetics in HIV-Infected Pregnant Women TY - research article VL - 7 ER -